BAXTER HEALTHCARE LIMITED
Get an alert when BAXTER HEALTHCARE LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2027-02-20 (in 9mo)
Last made up 2026-02-06
Watchouts
None on the register
Cash
£2M
+10.3% vs 2023
Net assets
£213M
-6.9% vs 2023
Employees
1,507
-8.3% vs 2023
Profit before tax
£58M
+18.3% vs 2023
Name history
Renamed 1 time since incorporation
- BAXTER HEALTHCARE LIMITED 1988-02-01 → present
- TRAVENOL LABORATORIES LIMITED 1948-11-18 → 1988-02-01
Net assets
2-year trend · vs Health Care median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £723,684,000 | £662,513,000 | |
| Operating profit | £46,078,000 | £59,294,000 | |
| Profit before tax | £49,225,000 | £58,222,000 | |
| Net profit | £37,592,000 | £46,261,000 | |
| Cash | £1,900,000 | £2,096,000 | |
| Total assets less current liabilities | £429,844,000 | £410,665,000 | |
| Net assets | £228,389,000 | £212,603,000 | |
| Equity | £228,389,000 | £212,603,000 | |
| Average employees | 1,644 | 1,507 | |
| Wages | £89,775,000 | £80,623,000 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | 6.4% | 8.9% | |
| Net margin | 5.2% | 7.0% | |
| Return on capital employed | 10.7% | 14.4% | |
| Current ratio | 3.38x | 4.04x | |
| Interest cover | 12.01x | 5.40x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- PricewaterhouseCoopers LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“After reviewing the Company's forecasts and projections, the directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. The Company is secured to continue its operating activities with financial support from the ultimate parent company if required. The Company therefore continues to adopt the going concern basis in preparing its financial statements.”
Group structure
- BAXTER HEALTHCARE LIMITED · parent
- Baxter Healthcare Pension Plan Trustees Limited 50%
- Baxter (Hellas) EPE 100%
- IC Net International Limited 100%
- Vantive Limited 100%
- Vantive Limited Liability Company 99.8%
Significant events
- “In January 2023, Baxter International Inc. ("BII") announced its intent to separate the Kidney Care segment into a separate company called Vantive. BII has undertaken a series of internal transactions in order to facilitate the global separation.”
- “On 31st January 2025, Baxter International Inc. completed the sale of Vantive to Carlyle.”
- “On 12 June 2025, the Company distributed intercompany loan receivable in the amount of £165,189K as a dividend to its shareholder.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 25 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| MACIEJ SMIALEK, Michal | Director | 2019-04-10 | Jul 1983 | Polish |
| PATTNI, Rajan Harish | Director | 2024-08-30 | Apr 1980 | British |
| REES, Natasha Patricia Zilma | Director | 2023-12-07 | Sep 1981 | British |
Show 25 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| CAGE, Colin James | Secretary | — | 2001-09-18 |
| GODDEN, Mark Edwin | Secretary | 2001-09-18 | 2012-08-03 |
| KIDD, Janet Louise | Secretary | 2012-08-03 | 2013-07-17 |
| ADEY, John Fuller | Director | — | 1992-12-31 |
| BAILEY, Andrew George | Director | 2002-10-31 | 2004-03-09 |
| BODDY, Malcolm Edward | Director | 1991-10-10 | 1993-07-30 |
| BRAHAM, Geoffrey Ernest | Director | 1996-12-02 | 2016-01-29 |
| CAMPBELL, Robert | Director | 1993-05-21 | 2002-02-21 |
| CHARD, Christopher Arthur Mark | Director | 1993-05-21 | 2004-07-08 |
| DAVEY, William David | Director | — | 1998-12-31 |
| GANTZ, Wilbur Harry | Director | — | 1992-08-13 |
| GARAY, Jon | Director | 2016-01-29 | 2019-04-10 |
| GOLDNEY, Andrew Neil | Director | 2015-06-29 | 2023-12-07 |
| KEENAN, Harry Patrick | Director | 2004-07-16 | 2014-01-31 |
| KIM, Julie So-Young | Director | 2014-01-17 | 2015-06-29 |
| MARKEY, Alan James | Director | 2015-06-29 | 2016-12-23 |
| ODWYER, Donald Paul | Director | — | 1991-10-10 |
| PETITT, Mark Ronald | Director | 2002-10-31 | 2004-09-30 |
| SCOTT, Nigel Robert | Director | 2003-06-19 | 2004-01-23 |
| TARRAS-WAHLBERG, Bo Anders Caspersson | Director | 2016-01-29 | 2024-08-30 |
| TATE, Thomas Alan | Director | 1996-02-15 | 1998-07-31 |
| UTTS, James Edgar | Director | 1998-09-01 | 2002-02-21 |
| WHITE, Tony Lee | Director | 1992-08-13 | 1995-10-04 |
| WILLIAMS, Richard Huw, Dr | Director | 2004-01-23 | 2006-12-21 |
| WILMOT, William Maurice | Director | 2002-02-21 | 2003-06-19 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Baxter Healthcare Holding Ltd | Corporate entity | Shares 75–100% | 2017-10-30 | Ceased 2017-10-30 |
| Baxter Europe Holdings Ltd | Corporate entity | Shares 75–100% | 2017-10-30 | Ceased 2017-10-30 |
| Baxter International Incorporated | Corporate entity | Shares 75–100% | 2017-10-30 | Active |
| Baxter Holding Bv | Corporate entity | Shares 75–100% | 2017-02-14 | Ceased 2017-10-30 |
Filing timeline
Last 20 of 197 total filings
Material constitutional events — rename, articles re-file, resolution
- 2024-05-13 MA Memorandum articles
- 2024-05-13 RESOLUTIONS Resolution
- 2024-05-13 CC04 Statement of companys objects
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-02-07 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-10-10 | AD02 | address | Change sail address company with old address new address | |
| 2025-10-04 | AA | accounts | Accounts with accounts type full | |
| 2025-06-19 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2025-06-19 | CH01 | officers | Change person director company with change date | |
| 2025-06-19 | CH01 | officers | Change person director company with change date | |
| 2025-06-18 | CH01 | officers | Change person director company with change date | |
| 2025-02-21 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-10-07 | AA | accounts | Accounts with accounts type full | |
| 2024-09-17 | AP01 | officers | Appoint person director company with name date | |
| 2024-09-17 | TM01 | officers | Termination director company with name termination date | |
| 2024-05-13 | MA | incorporation | Memorandum articles | |
| 2024-05-13 | RESOLUTIONS | resolution | Resolution | |
| 2024-05-13 | CC04 | change-of-constitution | Statement of companys objects | |
| 2024-03-05 | CH01 | officers | Change person director company with change date | |
| 2024-02-08 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-01-08 | AP01 | officers | Appoint person director company with name date | |
| 2024-01-08 | TM01 | officers | Termination director company with name termination date | |
| 2023-10-05 | AA | accounts | Accounts with accounts type full | |
| 2023-02-08 | CS01 | confirmation-statement | Confirmation statement with no updates |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 7
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
-8.5%
£723,684,000 £662,513,000
-
Cash
+10.3%
£1,900,000 £2,096,000
-
Net assets
-6.9%
£228,389,000 £212,603,000
-
Employees
-8.3%
1,644 1,507
-
Operating profit
+28.7%
£46,078,000 £59,294,000
-
Profit before tax
+18.3%
£49,225,000 £58,222,000
-
Wages
-10.2%
£89,775,000 £80,623,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. Periods don't have to be exactly 12 months apart — a long or short period (typical around incorporation or year-end changes) will distort the comparison. Lines a company doesn't report are omitted. About these numbers